Average monthly insurance premiums for popular plans on Healthcare.gov, the major Obamacare exchange, are slated to rise by 25 percent. Some consumers will see their health insurance premiums double.
Eager to find a scapegoat, some politicians have pointed to drug companies, citing a string of high-profile price hikes to support their claims. The public has listened; more than six in ten Americans support "government action" to lower prescription drug prices, according to a recent Kaiser Family Foundation survey.
What these politicians ignore, though, is that prescription drugs account for less than a fifth of overall health care expenditures.
